Pousset Geert, Bilsen Johan, Cohen Joachim, Chambaere Kenneth, Deliens Luc, Mortier Freddy
End-of-Life Care Research Group, Vrije Universiteit Brussel, 1090 Brussels, Belgium.
Arch Pediatr Adolesc Med. 2010 Jun;164(6):547-53. doi: 10.1001/archpediatrics.2010.59.
To estimate the prevalence of end-of-life decisions and to describe their characteristics and the preceding decision-making process in minors in Belgium.
Population-based postmortem anonymous physician survey.
Flanders, Belgium.
All physicians signing the death certificates of all patients (N = 250) aged 1 to 17 years who died between June 2007 and November 2008 in Flanders, Belgium.
Prevalence and characteristics of end-of-life decisions and the preceding decision-making process.
For 165 of the 250 deaths, a physician questionnaire was returned (70.5%). In 36.4%, death was preceded by an end-of-life decision. Drugs were administered to alleviate pain and symptoms with a possible life-shortening effect in 18.2% of all deaths, nontreatment decisions were made in 10.3%, and lethal drugs without the patient's explicit request were used in 7.9%. No cases of euthanasia, ie, the use of drugs with the explicit intention to hasten death at the patient's explicit request, were reported. Poor clinical prospects (84.6%) and low quality of life expectations (61.5%) were important reasons for the physicians to engage in end-of-life decisions. Parents were involved in decision making in 85.2% of these decisions, patients in 15.4%.
Medical end-of-life decisions are frequent in minors in Flanders, Belgium. Whereas parents were involved in most end-of-life decisions, the patients themselves were involved much less frequently, even when the ending of their lives was intended. At the time of decision making, patients were often comatose or the physicians deemed them incompetent or too young to be involved.
评估比利时未成年人临终决策的发生率,并描述其特征以及之前的决策过程。
基于人群的匿名尸检医师调查。
比利时弗拉芒大区。
2007年6月至2008年11月间在比利时弗拉芒大区死亡的所有1至17岁患者(N = 250)的死亡证明签字医师。
临终决策的发生率和特征以及之前的决策过程。
250例死亡病例中,有165例医师问卷被返还(70.5%)。在36.4%的病例中,死亡前做出了临终决策。在所有死亡病例中,18.2%使用药物缓解疼痛和症状,可能具有缩短生命的效果;10.3%做出了不治疗的决策;7.9%使用了未经患者明确要求的致命药物。未报告安乐死病例,即未报告应患者明确要求使用药物故意加速死亡的情况。临床前景不佳(84.6%)和对生活质量期望较低(61.5%)是医师做出临终决策的重要原因。在这些决策中,85.2%的决策有父母参与,15.4%有患者参与。
在比利时弗拉芒大区,未成年人的医疗临终决策很常见。虽然大多数临终决策有父母参与,但患者自身参与的频率要低得多,即使是在有意结束生命的情况下。在决策时,患者往往处于昏迷状态,或者医师认为他们无行为能力或年龄太小无法参与。